Figure 2.

Metabolic activity of human adipose-derived stem cells (hASCs) treated with different concentrations of cytochalasin B (CB). Metabolic activity of hASCs seeded at 4000 cells/cm² was assessed after treatment with 0.1, 1, or 10 μM CB, or 0.05% dimethyl sulfoxide (DMSO) (CB vehicle), or without treatment (CTR). Resazurin reduction was measured at 4, 24, 48 and 72 h from the beginning of the treatment. Data are expressed as mean percentages of reduced resazurin ± standard deviations (SD), n = 3; ** p < 0.01 vs. CTR.